FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

783913004: Product containing carmellose and durapatite in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3760779017 Carmellose- and hydroxyapatite-containing product in parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module
4042418019 Product containing carmellose and durapatite in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4042419010 Carboxymethylcellulose- and durapatite-containing product in parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Is a Product containing carmellose and durapatite (medicinal product) true Inferred relationship Existential restriction modifier
Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form true Inferred relationship Existential restriction modifier
Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Is a Product containing durapatite in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Has active ingredient Carmellose true Inferred relationship Existential restriction modifier 1
Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Has active ingredient Hydroxyapatite false Inferred relationship Existential restriction modifier 2
Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Has active ingredient Hydroxyapatite true Inferred relationship Existential restriction modifier 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only carmellose and durapatite in parenteral dose form (medicinal product form) Is a True Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start